{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:42Z","timestamp":1790320722405,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.exphem.2006.01.008","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T07:13:23Z","timestamp":1143616403000},"page":"486-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Identification of a new HLA-A2\u2013restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael","family":"Hundemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Condomines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaviana","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Terness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Belle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.exphem.2006.01.008_bib1","first-page":"140","article-title":"Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation","volume":"13","author":"Bjorkstrand","year":"1995","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2006.01.008_bib2","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2006.01.008_bib3","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2004-06-2387","article-title":"Outcomes for reduced-intensity allogenic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","article-title":"Graft-versus-myeloma effect: proof of principle","volume":"87","author":"Tricot","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2141.1996.419959.x","article-title":"Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients","volume":"92","author":"Bergenbrant","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.01.008_bib6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V91.7.2459","article-title":"Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses","volume":"91","author":"Osterborg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V94.2.673","article-title":"Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy","volume":"94","author":"Massaia","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib8","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma\u2014a feasibility study","volume":"93","author":"Reichardt","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2000.01958.x","article-title":"Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects","volume":"108","author":"Titzer","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.01.008_bib10","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2002-06-1925","article-title":"Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells","volume":"101","author":"Rasmussen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.leu.2403181","article-title":"Long\u2013term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy","volume":"18","author":"Coscia","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.01.008_bib12","first-page":"598","article-title":"Immunotherapeutic strategies for the treatment of plasma cell malignancies","volume":"27","author":"Treon","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2006.01.008_bib13","first-page":"1156","article-title":"Genes encoding tumor-specific antigens are expressed in human myeloma cells","volume":"94","author":"van Baren","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P","article-title":"The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells","volume":"30","author":"Pellat-Deceunynck","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.01.008_bib15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V97.5.1508","article-title":"Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma","volume":"97","author":"Lim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-3083.2002.01138.x","article-title":"Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogenic stem cell transplantation for Sp17-positive multiple myeloma","volume":"56","author":"Chiriva-Internati","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.exphem.2006.01.008_bib17","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2004-01-0366","article-title":"Enrichment of functional CD8 memory T cells specific for MUC-1 in bone marrow of patients with multiple myeloma","volume":"105","author":"Choi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V84.6.1922.1922","article-title":"A novel membrane antigen selectively expressed on terminally differentiated human B cells","volume":"84","author":"Goto","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1006\/bbrc.1999.0683","article-title":"Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells","volume":"258","author":"Ohtomo","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2006.01.008_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0888-7543(95)80171-H","article-title":"Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth","volume":"26","author":"Ishikawa","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.exphem.2006.01.008_bib21","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1182\/blood.V90.8.3179","article-title":"Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24","volume":"90","author":"Ozaki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib22","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma","volume":"83","author":"Zhang","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00172063","article-title":"MHC ligands and peptide motifs: 1st listing","volume":"41","author":"Rammensee","year":"1995","journal-title":"Immunogenetics"},{"key":"10.1016\/j.exphem.2006.01.008_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains","volume":"152","author":"Parker","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.01.008_bib25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/sj.leu.2401925","article-title":"Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro","volume":"14","author":"Tarte","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.01.008_bib26","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","article-title":"CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy","volume":"100","author":"Schultze","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.01.008_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.184.2.647","article-title":"Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1(27-35)","volume":"184","author":"Loftus","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.01.008_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<671::AID-IJC7>3.0.CO;2-E","article-title":"T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma","volume":"80","author":"Fagerberg","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2006.01.008_bib29","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2002-04-1250","article-title":"T-cell epitopes within the complementarity-determining and framework regions of the tumor derived immunoglobulin heavy chain in multiple myeloma","volume":"101","author":"Hansson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","article-title":"Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies","volume":"6","author":"Trojan","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2006.01.008_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2141.1998.00592.x","article-title":"Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma","volume":"100","author":"Wen","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.01.008_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0145-2126(00)00111-9","article-title":"MUC1 expression in plasmacytoma","volume":"25","author":"Paydas","year":"2001","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.exphem.2006.01.008_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.thj.6200053","article-title":"Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors","volume":"1","author":"Pellat-Deceunynck","year":"2000","journal-title":"Hematol J"},{"key":"10.1016\/j.exphem.2006.01.008_bib34","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood-2002-11-3580","article-title":"Testing of recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24","volume":"102","author":"Chiriva-Internati","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib35","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-04-0650","article-title":"Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1. 24","volume":"11","author":"Rew","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2006.01.008_bib36","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-04-1438","article-title":"Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma","volume":"106","author":"Jalili","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.01.008_bib37","article-title":"Molekulare Mechanismen der HLA-Assoziation von Autoimmunkrankheiten","author":"Friede","year":"2003","journal-title":"Thesis, Institut f\u00fcr Immunologie, Universit\u00e4t T\u00fcbingen"},{"key":"10.1016\/j.exphem.2006.01.008_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4049\/jimmunol.148.3.894","article-title":"Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide","volume":"148","author":"Carreno","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.01.008_bib39","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/jvi.67.4.2276-2284.1993","article-title":"Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein","volume":"67","author":"van Binnendijk","year":"1993","journal-title":"J Virol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:22:01Z","timestamp":1759566121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0301472X06000543"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.01.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a new HLA-A2\u2013restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}